News
AcouSort AB – Interim Report for the period July – September 2024
Summary of the interim report Significant events during the third quarterOn July 12, AcouSort announces that the Company and GenSensor will collaborate to combine AcouSort’s acoustofluidics technology with GenSensor’s Biology First Process Analytical Technology to accelerate bioprocess design and improve monitoring systems for bioreactor culturing. On July 23, AcouSort announces that the Company has been…
AcouSort secures working capital through H1, 2025
Through a consortium consisting of the company’s management, board of directors, founders and major shareholders, AcouSort has received loan guarantees of approximately SEK 4.5 million. Together with current cash position and known future revenues, the loan guarantees secure the execution of AcouSort’s planned activities into Q3 of 2025. AcouSort will now work to establish the…
Continued efforts expand AcouSort’s presence in the flow cytometry space
In order to further strengthen its presence in the flow cytometry space, AcouSort has initiated two important collaborations placing instruments at University of Ottawa, Canada, and Van Andel Institute, Michigan, USA, respectively. As earlier reported, AcouSort collaborates with Dr Vera Tang at University of Ottawa to develop applications concerning isolation of cells from dissociate tissue…
